The nation of Zimbabwe has turned down a substantial US health deal valued at 367 million US dollars (272 million pounds) spanning five years due to Washington's request for confidential information.
This move became public after a internal memorandum from December was leaked, revealing that Head of State Emmerson Mnangagwa felt the agreement was "skewed".
An official spokesman has since stated that the US was seeking health data for scientific study and commercial gain while was not willing to guarantee the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A medical body in Zimbabwe has urged further talks to reach a deal suitable to both sides so the country's vital HIV treatment initiative can proceed.
Wider Context
Zimbabwe's decision follows a similar case in neighbouring Kenya, where a high court suspended a similar health funding agreement following concerns were raised about the safety of Kenyans' medical information.
After returning to office last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to boost openness and responsibility.
According to reports, Sixteen nations in Africa have so far agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Declined Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense benefits for the people of Zimbabwe, particularly the 1.2 million currently on HIV treatment via US-supported initiatives," Tremont said.
However, official spokesman Nick Mangwana said the arrangement was "unequal".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, without any equivalent guarantee of benefiting from any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Effectively, our nation would supply the raw materials for medical research without any assurance that the end products would be accessible to our citizens should a new disease outbreak emerge."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were upending frameworks already established through the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential global health emergencies.
"This system is intended to guarantee that when a country provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections over the US deal "should not be misconstrued as opposition to America," he added.
"We are open to further discussions with our American counterparts on how future collaboration could be arranged in a manner that honours the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but urged that talks need to persist given that much of the nation's Aids initiatives relied on external financing.
"In cases where specific concerns arise, including those involving information security or agreement terms, these can frequently be addressed via technical clarification and mutually agreed protections," it said.
The halted deal emphasises the continuing debate between receiving vital foreign assistance and safeguarding a country's data in an ever more interconnected world.